NMPA Approval

Monosialotetrahexosylganglioside Sodium Injection

Approval Number

国药准字H20093980

Company北京赛升药业股份有限公司

Registration Date

September 6, 2024

Drug Information

Generic Name

单唾液酸四己糖神经节苷脂钠注射液

Brand Name

赛典

Dosage Form

注射剂（小容量注射剂）

Strength

2ml:20mg

Drug Type

化学药品

Registration Date

September 6, 2024

Company Information

Applicant Company

Company Name北京赛升药业股份有限公司

Company Address

北京市北京经济技术开发区兴盛街8号

Manufacturing Company

Company Name北京赛升药业股份有限公司

Company Address

北京市北京经济技术开发区兴盛街8号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

单唾液酸四己糖神经节苷脂钠注射液 - NMPA 批准文号 | MedPath